Somatic RET mutations, particularly the p.Met918Thr (M918T) variant, have been repeatedly associated with an unfavorable prognosis, including advanced tumor stage, higher T category, and increased rates of lymph node and distant metastases [23,47,48,49,50]. The gene discussed is RET; the disease is neoplasm.